Le rapport
Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde
1,273 rapports et plus encore
Alexion Pharmaceuticals Raises $40B in Public
Alexion Pharmaceuticals, a Biotech company based in 121 Seaport Boulevard, Boston, MA 02210, has raised $40B in Public at a $42B valuation led by AstraZeneca.
Where is AIML Company 121's Headquarters? Main Office Location
AIML Company 121's global headquarters is located at 121 Tech Drive, San Francisco, CA 90120. The office serves as the central hub for the company's AI/ML operations.
Seaport Therapeutics Raises $225M in Series B
Seaport Therapeutics, a HealthTech company based in Boston, MA, has raised $225M in Series B from multiple investors.
Seaport Therapeutics raises $225M Series B
Seaport Therapeutics raises $225M in Series B. Biotech developing neuropsychiatric therapies...
Alexion Pharmaceuticals raises $40B Public at $42B valuation
Alexion Pharmaceuticals raises $40B in Public at $42B valuation. Biopharmaceutical company...
Seaport Therapeutics raises $225M Series C at $1.2B valuation
Seaport Therapeutics raises $225M in Series C at $1.2B valuation. Neuropsychiatric disease treatments...
Seaport Therapeutics Raises $225 Million in Series B - October 21, 2024
Seaport Therapeutics announced $225 Million in Series B funding at a Undisclosed valuation. Seaport Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for neuropsychiatric disorders using prodrug technology ...
C3.ai Raises $125M in Series Unknown
C3.ai, a AI/ML company based in 1300 Seaport Boulevard, Redwood City, CA 94063, has raised $125M in Series Unknown at a $3B valuation led by TPG Capital, Breyer Capital, Sutter Hill Ventures.
Alexion Headquarters - Office Location & Address
Discover Alexion's headquarters at 121 Seaport Blvd, Boston, MA 02210. Rare disease treatments. Learn about the office facilities and work environment.
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.